PATRICIA TORRES: Open Payments
NPI 1558977306 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,862 in 96 payments from 13 companies in 2025. Trend: 2023 $1,699 · 2024 $2,670 · 2025 $1,862
Food & beverage: $1,862
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $352 |
| Alkermes, Inc. | 18 | $229 |
| Axsome Therapeutics, Inc. | 8 | $222 |
| Supernus Pharmaceuticals, Inc. | 6 | $182 |
| Vanda Pharmaceuticals Inc. | 10 | $168 |
| Otsuka America Pharmaceutical, Inc. | 17 | $165 |
| ABBVIE INC. | 13 | $157 |
| Janssen Pharmaceuticals, Inc | 2 | $142 |
| E.R. Squibb & Sons, L.L.C. | 5 | $120 |
| Corium, LLC | 5 | $64 |
Products named: CAPLYTA, Auvelity, ARISTADA, Qelbree, FANAPT, VRAYLAR, REXULTI, INVEGA SUSTENNA.
Industry payments across TX — which companies pay providers there.
